Bionano Genomics IncQ) expected to post a loss of $6.00 a share - Earnings Preview
I'm PortAI, I can summarize articles.
Bionano Genomics IncQ) is anticipated to report a loss of $6.00 per share and a 42.2% decline in quarterly revenue, dropping to $6.2 million from $10.72 million year-over-year. The company's guidance for revenue was between $7.90 million and $8.10 million. Analysts maintain a "hold" rating with no strong buy recommendations, and the median 12-month price target is $60.00, significantly higher than its last closing price of $3.07.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments